This is perplexing. But I'm not complaining. The only question I have is 'do I add to my position?'
I have a hard time believing #1, but it's feasible. #2 is certainly feasible, but will a fund really pay attention to this thing? #3--highly unlikely, agreed. Could they be partnering one of their other platforms? No way they partner ICT-107 at this stage...not until phase 2 is complete.
Investors are realizing this is a highly undervalued company. The more investors learn about this stock, the more demand will start to be generated for shares. I expect this stock price to look very different by the end of the year... even by Labor Day perhaps! Excellent pipeline and lead candidate drug.